Pan-Immune-Inflammation Value Predicts Disease Activity and Ocular Involvement in Behçet's Disease: A Case-Control Study [0.03%]
全免疫炎症值可预测贝赫切特病的疾病活动及眼炎发生：一种病例对照研究
Eman M Shawky,Maha S I Abdelrahman,Sara Farrag
Eman M Shawky
Objective/aim: Behçet's disease (BD) lacks distinctive laboratory findings, so this study aimed at evaluating the pan-immune-inflammation value (PIV), neutrophil to lymphocyte ratio (NLR), platelets to lymphocytes ratio ...
Giant Cell Myocarditis: Is It Time to Redeploy Cytokine Inhibitors? [0.03%]
巨细胞心肌炎：是否到了再次部署细胞因子抑制剂的时候了？
Deepak Nagra,Iyantha Sarindhi Kuruppurachchi,Kaiyang Song et al.
Deepak Nagra et al.
Giant cell myocarditis (GCM) is a rare, aggressive T-lymphocyte-mediated inflammatory cardiac disorder associated with high mortality. Diagnosis relies on endomyocardial biopsy, revealing lymphocytic infiltrates, granulomas, and myocyte nec...
The Hidden Enemy: A Case Report of Early-Onset Rheumatoid Vasculitis Masquerading as Peripheral Artery Disease [0.03%]
隐藏的敌人——一篇关于早期类风湿性血管炎伪装成外周动脉疾病的病例报告
Shrreya Agarawal,Gorantla Sai Susmitha,Joydeep Samanta et al.
Shrreya Agarawal et al.
Rheumatoid vasculitis (RV) is a rare, severe extra-articular manifestation of rheumatoid arthritis (RA), typically occurring after long-standing erosive disease. Advances in RA therapy have reduced its incidence; however, RV can occasionall...
Alexandros A Drosos,Paraskevi V Voulgari
Alexandros A Drosos
In the decades of the 1980s and 1990s, before the onset of biologic therapies for rheumatoid arthritis (RA) management, there was a significant number of patients who did not achieve remission or low disease activity (LDA), due to limited t...
Proceedings of the 2nd Symposium "Autoimmune Diseases -Clinical Unmet Needs in Systemic Autoimmune Diseases Guide Clinical, Translational, and Basic Research" [0.03%]
自身免疫病临床未满足需求国际研讨会-系统性自身免疫病临床、转化和基础研究指南分会摘要集
Loukas Chatzis,Ioanna Myrto Theofani,Ioanna Evdokia Galani et al.
Loukas Chatzis et al.
Response to Commentary [0.03%]
对评论的回应
Mahabaleshwar Mamadapur,Ramaswamy Subramanian
Mahabaleshwar Mamadapur
Renal Manifestations in VEXAS Syndrome: A Systematic Review of Clinical Features, Pathology, and Outcomes [0.03%]
VEXAS综合征的肾表现：临床特征、病理和结局的系统评价
Akhila Arya,Vishnu Mulavini,Rasiya Hashim et al.
Akhila Arya et al.
Objective: This review aimed to synthesise current literature on the clinical presentation, renal pathology, treatment, and outcomes of kidney involvement in VEXAS syndrome. ...
Comment on "Methotrexate-Induced Accelerated Nodulosis: A Case Series" [0.03%]
关于「甲氨蝶呤诱导的加速结节病：病例系列」的评论
Pavlos Stamatis
Pavlos Stamatis
Comment on "Methotrexate-Induced Accelerated Nodulosis: A Case Series" [Subramanian R et al, Mediterr J Rheumatol 2024;35(4):680-683]. ...
VEXAS Syndrome and IgG4-Related Disease: Coincidental Association or Pathogenetic Link? [0.03%]
VEXAS综合征与IgG4相关性疾病：巧合关联还是发病机制联系？
Senol Kobak,Mehmet Hilmi Dogu,Mehmet Aydogan et al.
Senol Kobak et al.
Predictors of Cyclophosphamide Resistance in Granulomatosis with Polyangiitis: A Retrospective Cohort Study [0.03%]
肉芽肿性多血管炎环磷酰胺耐药性的预测因素：一项回顾性队列研究
Pınar Akyüz Dağlı,Esra Kayacan Erdoğan,Hatice Ecem Konak et al.
Pınar Akyüz Dağlı et al.
Objective: Cyclophosphamide remains a cornerstone of remission induction therapy in granulomatosis with polyangiitis (GPA); however, the presence of resistant patients necessitating a switch to alternative agents, such as...